UK
UK
Jan-18
Cardiovascular Endocrinology Other Vascular Women's Health
Read moreJan-18
Dec-17
Endocrinology Pharmacoepidemiology
Read moreOct-17
Endocrinology Musculoskeletal Pharmacoepidemiology
Read moreOct-17
Endocrinology General Analysis Pharmacoepidemiology
Read moreSep-17
Endocrinology Pharmacoepidemiology
Read moreAug-17
Cardiovascular Endocrinology Pharmacoepidemiology
Read moreAug-17
Endocrinology Geriatrics Pharmacoepidemiology
Read moreJul-17
Endocrinology Pharmacoepidemiology
Read moreJul-17
Jul-17
Cardiovascular Endocrinology Pharmacoepidemiology
Read moreJun-17
Endocrinology Pharmacoepidemiology
Read more| Date | Title | Categories | |
|---|---|---|---|
| Jan-18 | Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: A population-based cohort study | Read more | |
| Jan-18 | Association between insulin-induced weight change and CVD mortality: Evidence from a historic cohort study of 18,814 patients in UK primary care | Read more | |
| Dec-17 | Premixed vs basal‐bolus insulin regimen in Type 2 diabetes: comparison of clinical outcomes from randomized controlled trials and real‐world data | Read more | |
| Oct-17 | Effect of Anti-Diabetic Medications on Fracture Risk in Type II Diabetes Mellitus | Read more | |
| Oct-17 | Implementation of Nice Guidance for the Treatment of Type 2 Diabetes | Read more | |
| Sep-17 | Treatment failure with sitagliptin compared to sulphonylureas for type 2 diabetes inadequately controlled on metformin | Read more | |
| Aug-17 | Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study | Read more | |
| Aug-17 | Comparative Effectiveness of Sitagliptin Compared to Sulphonylureas for Type 2 Diabetes Among Elderly Patients Inadequately Controlled on Metformin | Read more | |
| Jul-17 | Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes | Read more | |
| Jul-17 | Comparison of body mass index at diagnosis of diabetes in a multi‐ethnic population: A case‐control study with matched non‐diabetic controls | Read more | |
| Jul-17 | The effects of dual-therapy intensification with insulin or dipeptidylpeptidase-4 inhibitor on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A retrospective cohort study | Read more | |
| Jun-17 | All-cause mortality in patients with diabetes under glucagon-like peptide-1 agonists: A population-based, open cohort study | Read more |
